comparemela.com

Latest Breaking News On - Merck biopharma - Page 1 : comparemela.com

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

Study abroad veterans urge others to give it a try

Study abroad veterans urge others to give it a try
thefamuanonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thefamuanonline.com Daily Mail and Mail on Sunday newspapers.

Merck Korea launches infertility support program for employees

German chemicals giant Merck has launched a fertility benefit program for all employees working at its Korean unit to help address the nation’s severely low birth rate, the company said Monday. Earlier this month, the Korean unit became the tenth to join the program, established in October of last year and designed to to help Merck employees having difficulties in conceiving a pregnancy. The scheme was first ap.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.